PSA is not a cancer-specific biomarker as it is produced in both normal and cancerous prostate tissue and secreted into seminal fluid; it is therefore challenging to discriminate between prostate cancer and other prostatic diseases (e.g., benign prostatic hyperplasia and prostatitis) using PSA alone1,7,8. This evidence concerns the gene KLK3 and urogenital neoplasm.